                Figure 6.  DFS (232 cases) for TAM treated patients with breast carcinomas categorised according to the combinations in all evaluated cases of (A) ErbB-3 and ERÎ²1 expression, (B) ErbB-3 and P-Akt expression.Survival curves were generated according to the Kaplan-Meier method; statistical comparisons were made using the log-rank test.

